# Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss

> **NCT07292441** · PHASE3 · RECRUITING · sponsor: **Gan & Lee Pharmaceuticals.** · enrollment: 500 (estimated)

## Conditions studied

- Overweight or Obesity

## Interventions

- **DRUG:** GZR18 injection
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07292441
- **Lead sponsor:** Gan & Lee Pharmaceuticals.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-22
- **Primary completion:** 2027-09
- **Final completion:** 2027-10
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07292441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07292441, "Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT07292441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*